These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 3860666)

  • 1. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
    Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
    Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CA125 as a circulating tumor marker for ovarian cancer.
    Kuzuya K; Nozaki M; Chihara T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):949-57. PubMed ID: 3461071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum CA125 in malignant ovarian tumor--periodical monitoring and correlation with other tumor markers].
    Kawai M; Yamashita H; Hayashi T; Kamiya N; Kakihara M; Arii Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):402-10. PubMed ID: 3457877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
    Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
    Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
    Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of tumor markers in the treatment of patients with ovarian malignancies].
    Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors].
    Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1985 Feb; 33(2):173-7. PubMed ID: 3858562
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical value of tissue polypeptide antigen in ovarian carcinoma].
    Wu L; Sun J; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between serum CA125 level and second-look findings in ovarian cancers].
    Liu LY
    Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):287-9. PubMed ID: 1327702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.